Back to Trades
Chung Wendy
DirectorCIK 0001922605
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 2
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2025–2026
Across 2 filings between 2025–2026, Chung Wendy, Director, has disclosed $1.9M in transactions — all concentrated in Prime Medicine, Inc. (PRME). Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
2 loaded
| Jun 8 | PRME Prime Medicine, Inc. | Chung Wendy | Director | Award | $229.5K |
| Aug 5 | PRME Prime Medicine, Inc. | Chung Wendy | Director | Award | $1.7M |
2 filings